Thermo Fisher Scientific Inc.’s Stock Price Drops to $552.86, Slips by 3.26% in Recent Market Performance

Thermo Fisher Scientific Inc. (TMO)

552.86 USD -18.61 (-3.26%) Volume: 2.85M

Thermo Fisher Scientific Inc.’s stock price currently stands at 552.86 USD, experiencing a drop of -3.26% this trading session with a trading volume of 2.85M. However, the stock shows a positive trend with a Year-To-Date (YTD) percentage change of +6.27%, highlighting its resilient performance in the market.

Latest developments on Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. (NYSE:TMO) experienced a shift in its stock price today as Generate Investment Management Ltd sold 8,191 shares of the company. This event has contributed to the movement in Thermo Fisher Scientific Inc‘s stock price, as investors react to the sale. The decision by Generate Investment Management Ltd to offload a portion of their shares may have been influenced by various factors, impacting the overall market sentiment towards the company. It will be interesting to see how this development continues to shape the performance of Thermo Fisher Scientific Inc in the coming days.

Thermo Fisher Scientific Inc. on Smartkarma

Analyst coverage on Thermo Fisher Scientific Inc by Baptista Research on Smartkarma shows a bullish outlook on the company’s performance. According to the research reports, Thermo Fisher Scientific reported strong financial results for the fourth quarter of 2024, with a 5% year-over-year growth in revenue reaching $11.4 billion. The company also saw a 7% increase in adjusted operating income, totaling $2.72 billion, and an adjusted operating margin expansion by 50 basis points to 23.9%. Additionally, adjusted earnings per share (EPS) grew by 8% to $6.10, highlighting the company’s positive trajectory.

Furthermore, Baptista Research‘s analysis emphasizes Thermo Fisher Scientific’s expansion of clinical research and pharma services integration as key drivers of their bullish sentiment. The company’s third-quarter results of 2024 demonstrated robust financial performance, with quarterly revenue reaching $10.6 billion and adjusted operating income amounting to $2.36 billion. This resulted in an adjusted operating margin of 22.3% and an adjusted earnings per share (EPS) of $5.28, showcasing Thermo Fisher Scientific’s ability to generate consistent shareholder value through strategic initiatives and solid core business operations.

A look at Thermo Fisher Scientific Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Thermo Fisher Scientific Inc, a company that manufactures scientific instruments and consumables, has a mixed outlook according to Smartkarma Smart Scores. While the company scores well in terms of momentum, indicating strong market performance, it falls short in areas such as dividend and resilience. With a focus on growth and value, Thermo Fisher Scientific Inc is positioned to continue its upward trajectory in the scientific instruments industry.

Thermo Fisher Scientific Inc, known for its wide range of products and services for pharmaceutical and biotech companies, hospitals, universities, and government agencies, has a promising long-term outlook based on its overall Smartkarma Smart Scores. With a balanced score across different factors such as value, growth, and momentum, the company is expected to maintain its competitive edge in the market. Despite facing challenges in areas like dividend and resilience, Thermo Fisher Scientific Inc is well-positioned for continued success in the scientific instruments sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma